Evidence map›Paper›PMID 42200801›Full record

ArticleJournal of the American Chemical Society2026

A Bifunctional Aminoxyl-Bipyridine Peptide Catalyst for the Atroposelective Copper-Catalyzed Aerobic Oxidation of Biaryl Diols.

Halle M Marvich, Olivia C Langner, Nicolò Tampellini, Scott J Miller

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Halle M MarvichDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.
Olivia C LangnerDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0002-1875-8173
Nicolò TampelliniDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0002-6611-556X
Scott J MillerDepartment of Chemistry, Yale University, New Haven, Connecticut 06520, United States.ORCID 0000-0001-7817-1318

Funding

Site-Selective Catalysis for Bioactive Scaffold DiversificationR35GM132092 · NIGMS · YALE UNIVERSITY · PI Scott J Miller · 2019 to 2026
$6.3M
NIGMS NIH HHS R35 GM132092
6 · The paper itself

Abstract

Chiral aminoxyl catalysts have shown promise for applications in asymmetric oxidations but have been historically synthetically challenging to develop. The paucity of chiral catalysts is particularly severe in aerobic oxidations when cocatalysis involves the combined action of an aminoxyl species and a Cu-based metal complex. In these oxidations, the venerable bipyridine ligand (bpy) is most commonly employed to bind to the Cu metal center. The utility of bpy ligands, in this context and many others, has created great interest in the development of modular chiral variants. However, the design of efficient chiral versions within this ligand class remains a significant challenge. Herein, we report a bifunctional chiral peptide ligand featuring both an aminoxyl and a bipyridyl motif and demonstrate its utility in the copper(I)-catalyzed aerobic oxidation of biaryl diols to furnish axially chiral aldehydes. This catalyst was found to efficiently catalyze atroposelective oxidations using ambient air as the terminal oxidant. Additionally, catalyst bifunctionality was found to be essential for enantioselectivity in this desymmetrization, affording axially chiral products in up to >99.5:0.5

Indexed as

AlcoholsCopperPeptidesPyridinesCatalysisLigandsMolecular StructureOxidation-ReductionStereoisomerismAlcoholsCopperLigandsPeptidesPyridines

Identifiers

PMID42200801
PMCPMC13266993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.